Yves Charton

Publications (2)6 Total impact

• Article: Preparation and affinity profile of novel nicotinic ligands.

  Yves Charton, Claude Guillonneau, Brian Lockhart, Pierre Lestage, Solo Goldstein
  [show abstract] [hide abstract]
  ABSTRACT: Novel nicotinic ligands, characterized by the presence of an amino substituted cyclopropane ring connected to a pyridine nucleus, are described. Pharmacological investigation revealed that these compounds exhibit highest affinity for the rat alpha4beta2 subtype of the nicotinic receptor with no affinity for the muscarinic receptor. No appreciable affinity for the muscular or for the ganglionic nicotinic receptor was observed at concentrations up to 10 microM. The increase in cortical ACh release as well as a positive effect on memory in a social recognition test in rat are exemplified.
  Bioorganic & medicinal chemistry letters 04/2008; 18(6):2188-93. · 2.65 Impact Factor
• Article: Synthesis and pharmacological evaluation of new 1,2-dithiolane based antioxidants.

  Claude Guillonneau, Yves Charton, Yves-Michel Ginot, Marie-Victoire Fouquier-d'Hérouël, Marc Bertrand, Brian Lockhart, Pierre Lestage, Solo Goldstein
  [show abstract] [hide abstract]
  ABSTRACT: Molecules containing a dithiolane moiety are widely investigated due to their antioxidant properties. The archetypal representative of this class of compounds is lipoic acid and indeed the lipoic acid-dihydrolipoic acid couple is part of the antioxidant defence system of the cell. In the course of a program aiming to find improved antioxidants effective in vivo, we designed, synthesised and pharmacologically investigated new lipoic acid analogs. The salient feature of these structures is the connection, via a thioamide or a thiocarbamate, of a 1,2-dithiolane moiety bearing a carbon chain and a N-alkyl-substituted morpholine ring. It was expected that the antioxidant and chelating properties of these functional groups combined with the basicity of the morpholine ring will impact on the antioxidant as well as on the partition and solubility characteristics of the compounds. Indeed in vitro and in vivo pharmacological investigation showed that these new molecules and especially those containing a thiocarbamate linker possess superior antioxidant properties compared with alpha-lipoic acid and to the amide or carbamate linker analogs. In particular, some of these compounds efficiently cross the blood brain barrier (BBB) thus providing efficient protection from lethality in a situation of induced oxidative stress. Moreover the absence of the 1,2-dithiolane moiety does not completely abolish antioxidant effects thus demonstrating that these compounds are distinct new chemical entities and not merely lipoic acid prodrugs. The chemical and pharmacological features of these new antioxidants are presented and discussed in the following paper.
  European Journal of Medicinal Chemistry 02/2003; 38(1):1-11. · 3.35 Impact Factor